Divis Laboratories Ltd | DIVI - Equity Capital And Reserves

Stock Price
5,888.50
Daily Change
38.50 0.66%
Monthly
-6.97%
Yearly
9.33%
Q2 Forecast
5,728.83

Divis Laboratories Ltd reported INR154.13B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Aurobindo Pharma INR 350.34B 23.87B Sep/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Lupin INR 196.33B 23.38B Sep/2025
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 251.33M 16.2M Dec/2025
Tilray USD 1.58B 39.08M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025